期刊文献+

大肠癌患者血清基质金属蛋白酶-7含量的临床意义(英文) 被引量:2

Clinical significance of serum matrix metalloproteinases-7 in patients with colorectal carcinoma
暂未订购
导出
摘要 目的:评估大肠癌患者血清MMP-7含量及其临床意义。方法:术前应用免疫酶联反应技术对50例大肠癌患者以及36例健康对照者的血清MMP-7含量进行检测,同时也检测这些患者血清CEA、CA19-9以及CA24-2含量。将大肠癌患者的血清MMP-7及其它肿瘤标志物的含量与健康对照者进行了比较。对不同临床病理分期的大肠癌患者血清MMP-7含量进行评估。结果:研究发现多数大肠癌患者的血清MMP-7含量升高。大肠癌患者的血清MMP-7含量,分布范围0.72-28.69ng/ml(平均4.41ng/ml;中位4.19ng/ml),显著高于健康对照者,分布范围0.69-3.97ng/ml(平均1.62ng/ml;中位1.36ng/ml)(P<0.01)。大肠癌患者的血清MMP-7平均阳性率(46%)与CEA(30%),CA19-9(26%)及CA24-2(24%)相比均升高(P<0.05)。进展期肿瘤患者血清MMP-7含量显著高于早期肿瘤患者(P<0.05)。结论:血清MMP-7有可能成为大肠癌患者临床监测标志物。 Objective: To evaluate serum levels of MMP -7 and its clinical significance in patients with colorectal carcinoma. Methods:MMP -7 in serum was examined prior to surgery on 50 patients with colorectal cancer as well as from 36 healthy normal controls by using a quantitative sandwich enzyme immunoassay technique, and serum carcino-embryonic antigen (CEA), CA19 -9 and CA24 -2 levels were also examined in the same patients. Serum MMP -7 levels in colorectal carcinoma patients were compared with other tumor markers as well as that in healthy controls. In addition, MMP-7 serum concentrations in patients with different clinicopathological stages of colorectal carcinoma were also evaluated. Results:The majority of the patients with colorectal carcinoma were found to have high concentrations of serum MMP -7. MMP -7 levels in patients with colorectal cancer, ranged from 0.72 -28.69ng/ml (mean, 4.41ng/ml; median, 4. 19ng/ml) , were significantly higher than levels in sera from healthy individuals, ranged from 0.69 to 3.97 ng/ml (mean, 1.62ng/ml; median, 1.36ng/ml) (P〈0.01). The mean positive percentage of MMP -7 (46%) compared with CEA (30%) , CA19 -9 (26%) and CA24 -2 (24%) serum concentration being higher in colorectal patients (P〈0. 05). MMP -7 serum concentrations of patients with advanced stage carcinoma were significantly higher compared to patients with early stage cancer (P 〈0.05). Conclusion;The present data indicate that the elevation of serum levels of MMP - 7 may be a useful marker for clinical monitoring of colorectal carcinoma patients.
出处 《现代肿瘤医学》 CAS 2010年第6期1160-1164,共5页 Journal of Modern Oncology
基金 中国博士后科学基金资助项目(编号:20073138)
关键词 基质金属蛋白酶-7 大肠癌 血清 肿瘤标志物 matrix metalloproteinases -7 serum colorectal carcinoma tumor marker
  • 相关文献

参考文献22

  • 1Jemal A,Thomas A,Murray T,et al.Cancer statistics[J].CA Cancer J Clin,2002,52:23-47.
  • 2McLeod HL,Murray GI.Tumour markers of prognosis in colorectal cancer[J].Br J Cancer,1999,79:191-203.
  • 3Cintin C,Johnansen JS,Christensen IJ,et al.High serum YKL-40 level after surgery for colorectal carcinoma is related to short sur-vival[J].Cancer,2002,95:267-274.
  • 4Malafosse R,Penna C,Sa-Cunha A,et al.Surgical management of hepatic metastases from colorectal malignancies[J].Ann Oncol,2001,12:887-894.
  • 5Adam R,Avisar E,Ariche A,et al.Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal[J].Ann Surg Oncol,2001,8:347-353.
  • 6Duffy MJ.Carcinoembryonic antigen as a marker for colorectal cancer:Is it clinically useful[J] ? Clin Chem,2001,47:624-630.
  • 7Berman JM,Cheung RJ,Weinberg DS.Surveillance after colorectal cancer resection[J].Lancet,2000,355:395-399.
  • 8Carriquiry LA,Pineyro A.Should carcinoembryonic antigen be used in the management of patients with colorectal cancer[J] ? Dis Colon Rectum,1999,42:921-929.
  • 9Audisio RA,Robertson C.Colorectal cancer follow-up:Perspectives for future studies[J].Eur J Surg Oncol,2000,26:329-337.
  • 10Schiedeck TH,Wellm C,Roblick UJ,et al.Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay[J].Dis Colon Rectum,2003,46:818-825.

同被引文献30

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部